vs

Side-by-side financial comparison of Spectral AI, Inc. (MDAI) and Peraso Inc. (PRSO). Click either name above to swap in a different company.

Spectral AI, Inc. is the larger business by last-quarter revenue ($4.1M vs $2.9M, roughly 1.4× Peraso Inc.). Spectral AI, Inc. runs the higher net margin — 25.7% vs -43.3%, a 69.1% gap on every dollar of revenue. On growth, Peraso Inc. posted the faster year-over-year revenue change (-22.0% vs -46.3%). Over the past eight quarters, Peraso Inc.'s revenue compounded faster (1.0% CAGR vs -19.6%).

Spectral AI, Inc. is a medical technology firm specializing in AI-powered diagnostic imaging solutions primarily for burn and wound care. It develops non-invasive imaging tools that enable healthcare providers to deliver faster, more accurate treatment assessments, serving clinical and healthcare partner networks across North America and European markets.

Peraso Inc. is a semiconductor technology firm specializing in the design and production of high-performance millimeter wave (mmWave) integrated circuits and modules. It delivers 5G and next-generation wireless connectivity solutions for telecom infrastructure, industrial IoT, fixed wireless access and consumer electronics segments, serving customers across North America, Asia Pacific and European markets.

MDAI vs PRSO — Head-to-Head

Bigger by revenue
MDAI
MDAI
1.4× larger
MDAI
$4.1M
$2.9M
PRSO
Growing faster (revenue YoY)
PRSO
PRSO
+24.3% gap
PRSO
-22.0%
-46.3%
MDAI
Higher net margin
MDAI
MDAI
69.1% more per $
MDAI
25.7%
-43.3%
PRSO
Faster 2-yr revenue CAGR
PRSO
PRSO
Annualised
PRSO
1.0%
-19.6%
MDAI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MDAI
MDAI
PRSO
PRSO
Revenue
$4.1M
$2.9M
Net Profit
$1.1M
$-1.2M
Gross Margin
45.2%
52.2%
Operating Margin
-54.9%
-44.6%
Net Margin
25.7%
-43.3%
Revenue YoY
-46.3%
-22.0%
Net Profit YoY
113.9%
20.3%
EPS (diluted)
$0.04
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDAI
MDAI
PRSO
PRSO
Q4 25
$4.1M
$2.9M
Q3 25
$3.8M
$3.2M
Q2 25
$5.1M
$2.2M
Q1 25
$6.7M
$3.9M
Q4 24
$7.6M
$3.7M
Q3 24
$8.2M
$3.8M
Q2 24
$7.5M
$4.2M
Q1 24
$6.3M
$2.8M
Net Profit
MDAI
MDAI
PRSO
PRSO
Q4 25
$1.1M
$-1.2M
Q3 25
$-3.6M
$-1.2M
Q2 25
$-8.0M
$-1.8M
Q1 25
$2.9M
$-471.0K
Q4 24
$-7.6M
$-1.6M
Q3 24
$-1.5M
$-2.7M
Q2 24
$-2.9M
$-4.4M
Q1 24
$-3.2M
$-2.0M
Gross Margin
MDAI
MDAI
PRSO
PRSO
Q4 25
45.2%
52.2%
Q3 25
42.7%
56.2%
Q2 25
45.2%
48.3%
Q1 25
47.2%
69.3%
Q4 24
44.0%
56.3%
Q3 24
44.9%
47.0%
Q2 24
44.3%
55.5%
Q1 24
46.6%
46.4%
Operating Margin
MDAI
MDAI
PRSO
PRSO
Q4 25
-54.9%
-44.6%
Q3 25
-88.1%
-36.8%
Q2 25
-41.9%
-80.0%
Q1 25
-13.4%
-13.3%
Q4 24
-14.6%
-44.3%
Q3 24
-10.8%
-70.3%
Q2 24
-32.7%
-105.6%
Q1 24
-33.9%
-128.9%
Net Margin
MDAI
MDAI
PRSO
PRSO
Q4 25
25.7%
-43.3%
Q3 25
-93.7%
-37.4%
Q2 25
-157.3%
-82.4%
Q1 25
43.2%
-12.2%
Q4 24
-99.8%
-42.4%
Q3 24
-18.4%
-70.6%
Q2 24
-38.3%
-104.4%
Q1 24
-50.7%
-72.1%
EPS (diluted)
MDAI
MDAI
PRSO
PRSO
Q4 25
$0.04
$-0.09
Q3 25
$-0.13
$-0.17
Q2 25
$-0.31
$-0.31
Q1 25
$0.11
$-0.10
Q4 24
$-0.42
$0.36
Q3 24
$-0.08
$-0.98
Q2 24
$-0.16
$-1.88
Q1 24
$-0.19
$-1.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDAI
MDAI
PRSO
PRSO
Cash + ST InvestmentsLiquidity on hand
$15.4M
$2.9M
Total DebtLower is stronger
$9.3M
Stockholders' EquityBook value
$-5.7M
$4.6M
Total Assets
$21.4M
$6.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDAI
MDAI
PRSO
PRSO
Q4 25
$15.4M
$2.9M
Q3 25
$10.5M
Q2 25
$10.5M
Q1 25
$14.1M
Q4 24
$5.2M
$3.3M
Q3 24
$3.7M
$1.3M
Q2 24
$6.9M
$1.9M
Q1 24
$10.2M
$2.4M
Total Debt
MDAI
MDAI
PRSO
PRSO
Q4 25
$9.3M
Q3 25
Q2 25
Q1 25
$7.8M
Q4 24
$2.8M
Q3 24
$1.0M
Q2 24
Q1 24
Stockholders' Equity
MDAI
MDAI
PRSO
PRSO
Q4 25
$-5.7M
$4.6M
Q3 25
$-8.2M
$3.6M
Q2 25
$-9.2M
$3.0M
Q1 25
$-1.6M
$3.6M
Q4 24
$-7.3M
$3.5M
Q3 24
$-4.8M
$2.0M
Q2 24
$-4.7M
$3.6M
Q1 24
$-2.5M
$6.7M
Total Assets
MDAI
MDAI
PRSO
PRSO
Q4 25
$21.4M
$6.1M
Q3 25
$15.3M
$6.2M
Q2 25
$16.0M
$5.5M
Q1 25
$20.7M
$6.7M
Q4 24
$12.1M
$7.2M
Q3 24
$11.6M
$7.2M
Q2 24
$13.9M
$9.8M
Q1 24
$15.5M
$11.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDAI
MDAI
PRSO
PRSO
Operating Cash FlowLast quarter
$-2.6M
$-1.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-2.43×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDAI
MDAI
PRSO
PRSO
Q4 25
$-2.6M
$-1.1M
Q3 25
$-2.5M
$-1.5M
Q2 25
$-3.4M
$-2.0M
Q1 25
$-1.5M
$-966.0K
Q4 24
$469.0K
$-687.0K
Q3 24
$-1.6M
$-683.0K
Q2 24
$-5.4M
$-659.0K
Q1 24
$-2.7M
$-2.5M
Free Cash Flow
MDAI
MDAI
PRSO
PRSO
Q4 25
Q3 25
$-1.6M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
MDAI
MDAI
PRSO
PRSO
Q4 25
Q3 25
-48.9%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
MDAI
MDAI
PRSO
PRSO
Q4 25
Q3 25
1.1%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
MDAI
MDAI
PRSO
PRSO
Q4 25
-2.43×
Q3 25
Q2 25
Q1 25
-0.52×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MDAI
MDAI

Segment breakdown not available.

PRSO
PRSO

Products$2.8M96%
Other$105.0K4%

Related Comparisons